Table 1 Baseline characteristics of patients with diabetes and their matched general population comparison cohort
Diabetes patients (n = 5734) | General population (n = 28,670) | |||
|---|---|---|---|---|
N | % | N | % | |
Male sex | 2997 | 52.3 | 14,985 | 52.3 |
Median age (IQR) | 62 years (53-70) | 62 years (53-70) | ||
Family history of ischemic heart diseasea | ||||
Yes | 2058 | 35.9 | – | – |
Missing | 670 | 11.7 | – | – |
Smokinga | ||||
Active | 1070 | 18.7 | – | – |
Former | 2024 | 35.3 | – | – |
Never | 2008 | 35.0 | – | – |
Missing | 632 | 11.0 | – | – |
CAG procedural indicationa | ||||
STEMI | 112 | 2.0 | – | – |
NSTEMI | 259 | 4.5 | – | – |
Unstable AP | 190 | 3.3 | – | – |
Stable AP | 2666 | 46.5 | – | – |
Arrhythmia | 228 | 4.0 | – | – |
Valvular disease | 665 | 11.6 | – | – |
Cardiomyopathy | 613 | 10.7 | – | – |
Other | 899 | 15.7 | – | – |
Missing | 102 | 1.8 | – | – |
Comorbidity | ||||
Diabetes | 5734 | 100.0 | 2041 | 7.1 |
Chronic pulmonary disease | 626 | 10.9 | 1123 | 3.9 |
Hypertension | 3362 | 58.6 | 3110 | 10.8 |
Peripheral artery disease | 214 | 3.7 | 456 | 1.6 |
Heart failure | 991 | 17.3 | 262 | 0.9 |
Atrial fibrillation | 1070 | 18.7 | 979 | 3.4 |
Ischemic stroke | 201 | 3.5 | 285 | 1.0 |
Hemorrhagic stroke | 12 | 0.2 | 69 | 0.2 |
MI < 30 days after inclusion | 2 | 0.0 | 6 | 0.0 |
Comedication | ||||
Aspirin | 3535 | 61.6 | 3455 | 12.1 |
ADP-inhibitors | 261 | 4.6 | 286 | 1.0 |
Vitamin K-antagonists | 909 | 15.9 | 830 | 2.9 |
DOAC | 182 | 3.2 | 148 | 0.5 |
Statin | 4140 | 72.2 | 5423 | 18.9 |
Beta-blocker | 3118 | 54.4 | 3227 | 11.3 |
ACE-inhibitor | 2659 | 46.4 | 3832 | 13.4 |
ARB | 1698 | 29.6 | 2870 | 10.0 |
Thiazide | 1209 | 21.1 | 2879 | 10.0 |
Calcium-blocker | 2050 | 35.8 | 3669 | 12.8 |
Insulin | 1631 | 28.4 | 568 | 2.0 |
Non-insulin anti-diabetes agents | 3658 | 63.8 | 1484 | 5.2 |